Cutaneous melanoma (CM) is potentially the most dangerous form of skin tumor and causes
90% of skin cancer mortality. A unique collaboration of multi-disciplinary experts from the …

Checkpoint inhibitor-based immunotherapies that target cytotoxic T lymphocyte antigen 4
(CTLA4) or the programmed cell death 1 (PD1) pathway have achieved impressive success …

Background Previous results from this trial showed longer overall survival after treatment
with nivolumab plus ipilimumab or with nivolumab monotherapy than with ipilimumab …

Advances in Melanoma Treatment The incidence of melanoma has increased, but mortality
has declined with improved management. Sentinel-node sampling has reduced morbidity …

A unique collaboration of multidisciplinary experts from the European Dermatology Forum,
the European Association of Dermato-Oncology and the European Organization for …

Cutaneous melanoma (CM) is potentially the most dangerous form of skin tumour and
causes 90% of skin cancer mortality. A unique collaboration of multi-disciplinary experts …

Melanoma is the deadliest form of skin cancer. Distinguishing melanoma lesions from non-
melanoma lesions has however been a challenging task. Many Computer Aided Diagnosis …

Background Approximately 50% of melanomas harbor activating (V600) mutations in the
serine–threonine protein kinase B-RAF (BRAF). The oral BRAF inhibitor vemurafenib …

Background An improvement in overall survival among patients with metastatic melanoma
has been an elusive goal. In this phase 3 study, ipilimumab—which blocks cytotoxic T …

Melanoma is a highly aggressive and life-threatening form of skin cancer that accounts for a
significant proportion of cancer-related deaths worldwide. Although conventional cancer …